Related Experiment Video
Updated: Jun 27, 2025

Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
MMPs-responsive silk spheres for controlled drug release within tumor microenvironment.
Kamil Kucharczyk1, Anna Florczak1, Alicja Kaminska2
1Department of Cancer Immunology, Poznan University of Medical Sciences, 61-866 Poznan, Poland; Department of Diagnostics and Cancer Immunology, Greater Poland Cancer Centre, 61-866 Poznan, Poland.
Bioengineered silk spheres functionalized with MMP-responsive peptides enable targeted drug delivery. These smart silk nanospheres degrade in the tumor microenvironment, releasing doxorubicin (Dox) specifically where needed.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Cancer Research
Background:
- Silk is a biocompatible and biodegradable material suitable for creating nanospheres.
- The tumor microenvironment (TME) overexpresses matrix metalloproteinases (MMPs), presenting a target for drug delivery.
- Functionalizing silk with specific peptides can yield particles with tailored properties for TME targeting.
Purpose of the Study:
- To develop and evaluate bioengineered spider silk spheres functionalized with MMP-responsive peptides for targeted drug release within the TME.
- To investigate the degradation and drug release profiles of these silk spheres in response to MMP enzymes and cancer cells.
Main Methods:
- Production of soluble bioengineered silks (MS12.2MS1, MS12.9MS1, MS22.9MS2) and corresponding silk spheres.
- Functionalization of silk spheres with MMP-2 or MMP-2/9 responsive peptides.
- Loading of doxorubicin (Dox) into the functionalized silk spheres.
- Analysis of silk sphere degradation and Dox release upon treatment with MMP-2/9 enzymes and in the presence of cancer cells in 2D and 3D spheroid models.
Main Results:
- All functionalized silk spheres showed specific degradation by MMP-2/9.
- MS22.9MS2 nanospheres exhibited the highest degradation and Dox release after enzyme treatment.
- Functionalized spheres degraded and released their payload in the presence of MMP-2/9-releasing cancer cells.
- Controlled degradation and drug release were observed in 2D and 3D cancer models using MS22.9MS2 particles, unlike control MS2 spheres.
Conclusions:
- Bioengineered silk spheres can be functionalized with MMP-responsive peptides for targeted drug delivery.
- The MS22.9MS2 nanosphere formulation demonstrates efficient degradation and controlled doxorubicin release within the tumor microenvironment.
- This silk-based system offers a promising approach for localized cancer therapy by exploiting TME-specific enzyme activity.
More Related Videos
09:11Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020